Cargando…

C‐reactive protein flare‐response predicts long‐term efficacy to first‐line anti‐PD‐1‐based combination therapy in metastatic renal cell carcinoma

OBJECTIVES: Immune checkpoint blockade (IO) has revolutionised the treatment of metastatic renal cell carcinoma (mRCC). Early C‐reactive protein (CRP) kinetics, especially the recently introduced CRP flare‐response phenomenon, has shown promising results to predict IO efficacy in mRCC, but has only...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klümper, Niklas, Schmucker, Philipp, Hahn, Oliver, Höh, Benedikt, Mattigk, Angelika, Banek, Severine, Ellinger, Jörg, Heinzelbecker, Julia, Sikic, Danijel, Eckstein, Markus, Strauß, Arne, Zengerling, Friedemann, Hölzel, Michael, Zeuschner, Philip, Kalogirou, Charis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648498/ https://www.ncbi.nlm.nih.gov/pubmed/34925829 http://dx.doi.org/10.1002/cti2.1358

Ejemplares similares

Early CRP kinetics to predict long‐term efficacy of first‐line immune‐checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real‐world experience applying different CRP kinetics definitions
por: Hoeh, Benedikt, et al.
Publicado: (2023)

Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial
por: Saal, Jonas, et al.
Publicado: (2023)

C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer
por: Klümper, Niklas, et al.
Publicado: (2022)

Pretreatment albumin is a prognostic and predictive biomarker for response to atezolizumab across solid tumors
por: Saal, Jonas, et al.
Publicado: (2023)

Integrating On-Treatment Modified Glasgow Prognostic Score and Imaging to Predict Response and Outcomes in Metastatic Renal Cell Carcinoma
por: Saal, Jonas, et al.
Publicado: (2023)

Insights into Urologic Cancer
por: Klümper, Niklas, et al.
Publicado: (2023)

Downstream neighbor of SON (DONSON) is associated with unfavorable survival across diverse cancers with oncogenic properties in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

CTLA4 promoter hypomethylation is a negative prognostic biomarker at initial diagnosis but predicts response and favorable outcome to anti-PD-1 based immunotherapy in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2021)

Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance
por: Klümper, Niklas, et al.
Publicado: (2023)

PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
por: Klümper, Niklas, et al.
Publicado: (2023)

Efficacy of Vinflunine for Patients with Metastatic Urothelial Cancer after Immune Checkpoint Inhibitor Pretreatment—A Retrospective Multicenter Analysis
por: Riedel, Felix, et al.
Publicado: (2022)

Downstream Neighbor of SON (DONSON) Expression Is Enhanced in Phenotypically Aggressive Prostate Cancers
por: Klümper, Niklas, et al.
Publicado: (2020)

Two Years of Gynecomastia Caused by Leydig Cell Tumor
por: Zeuschner, Philip, et al.
Publicado: (2018)

Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review
por: Zengerling, Friedemann, et al.
Publicado: (2022)

LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cell carcinoma
por: Klümper, Niklas, et al.
Publicado: (2020)

How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence
por: Winter, Christian, et al.
Publicado: (2022)

Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? A systematic review
por: Busch, Jonas, et al.
Publicado: (2022)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysis
por: Kalogirou, Charis, et al.
Publicado: (2020)

Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
por: Breyer, Johannes, et al.
Publicado: (2023)

CD103+ Tissue Resident T-Lymphocytes Accumulate in Lung Metastases and Are Correlated with Poor Prognosis in ccRCC
por: Sanders, Christine, et al.
Publicado: (2022)

Wahlfach Robotische Chirurgie – Faszination Lehre(n)?
por: Zeuschner, Philip, et al.
Publicado: (2022)

Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors
por: Klümper, Niklas, et al.
Publicado: (2015)

First-line salvage treatment options for germ cell tumor patients failing stage-adapted primary treatment: A comprehensive review compiled by the German Testicular Cancer Study Group
por: Pfister, David, et al.
Publicado: (2022)

Gonadotropin-releasing hormone antagonists versus standard androgen suppression therapy for advanced prostate cancer A systematic review with meta-analysis
por: Kunath, Frank, et al.
Publicado: (2015)

CircEHD2, CircNETO2 and CircEGLN3 as Diagnostic and Prognostic Biomarkers for Patients with Renal Cell Carcinoma
por: Frey, Lisa, et al.
Publicado: (2021)

Cultivation of Clear Cell Renal Cell Carcinoma Patient-Derived Organoids in an Air-Liquid Interface System as a Tool for Studying Individualized Therapy
por: Esser, Laura K., et al.
Publicado: (2020)

Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review
por: Ruf, Christian G., et al.
Publicado: (2022)

Solar flares
por: Jones, Sarah L
Publicado: (2016)

Flare stars
por: Gurzadyan, G A, et al.
Publicado: (1980)

Solar flares
por: Švestka, Zdeněk
Publicado: (1976)

Flare Observations
por: Benz, Arnold O.
Publicado: (2008)

Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma
por: Schrödter, Sarah, et al.
Publicado: (2016)

Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression
por: Klümper, Niklas, et al.
Publicado: (2017)

Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside
por: Solimando, Antonio Giovanni, et al.
Publicado: (2022)

On the Potential of the RST-FLARE Algorithm for Gas Flaring Characterization from Space
por: Faruolo, Mariapia, et al.
Publicado: (2018)

Comprehensive Analysis of N6-Methyladenosine (m6A) Writers, Erasers, and Readers in Cervical Cancer
por: Condic, Mateja, et al.
Publicado: (2022)

Comprehensive immunohistochemical analysis of N6-methyladenosine (m6A) writers, erasers, and readers in endometrial cancer
por: Ralser, Damian J., et al.
Publicado: (2022)

Prognostic impact of molecular muscle-invasive bladder cancer subtyping approaches and correlations with variant histology in a population-based mono-institutional cystectomy cohort
por: Weyerer, Veronika, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iiu1iva5vn2m3spsar9k00n6l0